Tower Research Capital (TRC)’s Centogene N.V. Common Shares CNTG Stock Holding History

Tower Research Capital (TRC)’s Portfolio CNTG Stock Details CNTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-405	Closed	-$2K	–	6667
2022 Q1	$2K	Sell	405 -549	-58%	-$2.3K	﹤0.01%	5634
2021 Q4	$5K	Buy	954 +950	+23,750%	+$7.74K	﹤0.01%	5213
2021 Q3	$0	Sell	4 -51	-93%	-$552	﹤0.01%	6286
2021 Q2	$1K	Sell	55 -834	-94%	-$8.76K	﹤0.01%	5283
2021 Q1	$11K	Sell	889 -712	-44%	-$8.5K	﹤0.01%	4329
2020 Q4	$18K	Sell	1,601 -3,317	-67%	-$38K	﹤0.01%	3945
2020 Q3	$47K	Buy	4,918 +3,499	+247%	+$44.5K	﹤0.01%	3564
2020 Q2	$33K	Buy	+1,419	New	+$26.6K	﹤0.01%	3390
2020 Q1	–	Sell	-313	Closed	-$3K	–	4094
2019 Q4	$3K	Buy	+313	New	+$3.73K	﹤0.01%	2984

Other funds holding CNTG

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Tower Research Capital (TRC)'s CNTG Position: Q2 2022 in Review

Tower Research Capital (TRC) sold out of Centogene N.V. Common Shares (CNTG) in Q2 2022, closing a stake of 405 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in CNTG in Q4 2019 and held it in 9 quarters. The position peaked at $47K in Q3 2020. 15 funds tracked by Wall St. Rank hold CNTG as of Q2 2022.

Tower Research Capital (TRC) reported no remaining Centogene N.V. Common Shares position as of Q2 2022 after selling out during the quarter.
Tower Research Capital (TRC) sold 405 Centogene N.V. Common Shares shares in Q2 2022, an estimated $2K.
Tower Research Capital (TRC) first reported a position in Centogene N.V. Common Shares in Q4 2019 and held it in 9 quarters.
Tower Research Capital (TRC)'s Centogene N.V. Common Shares position peaked at $47K in Q3 2020.
15 funds tracked by Wall St. Rank held Centogene N.V. Common Shares as of Q2 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.